Minister Of Health,Nutrition and Indigenous Medicine Dr.Rajitha Senaratne has instructed the Health Ministry Secretary Anura Jayawikrame to investigate on some oncologists attached to the "Apeksha"Hospital in Maharagama who are spreading rumours among patients that the Hospital has a drug shortage .
Some oncologists attached to Apeksha Hospital who refused to prescribe the essential Cancer Drug imported from Russia are behind the creating of this false drug shortage story the Minister has stated during a health institution heads meeting held at the Health Ministry .
Minister has advised the Health Minustry Secretary to conduct an investigation on this and submit an investigation report to him within one week period.After receiving the investigation report a disciplinary action will be taken against those oncologists who are refusing to accept the Russian cancer drug the Health Minister said.
A group of Oncologists attached to the Apeksha Hospital recently toured Denmark and a Pharmaceutical company importing Cancer Drugs to Sri Lanka was organized this tour Health Minister has stressed while stating a seperate investigation should be conducted in this regard.
Some oncologists attached to Apeksha Hospital who refused to prescribe the essential Cancer Drug imported from Russia are behind the creating of this false drug shortage story the Minister has stated during a health institution heads meeting held at the Health Ministry .
Minister has advised the Health Minustry Secretary to conduct an investigation on this and submit an investigation report to him within one week period.After receiving the investigation report a disciplinary action will be taken against those oncologists who are refusing to accept the Russian cancer drug the Health Minister said.
A group of Oncologists attached to the Apeksha Hospital recently toured Denmark and a Pharmaceutical company importing Cancer Drugs to Sri Lanka was organized this tour Health Minister has stressed while stating a seperate investigation should be conducted in this regard.
No comments:
Post a Comment